FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Zangerle John Adam 2. Issuer Name and Ticker or Trading Symbol STERIS plc [ STE ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Sr. VP, Gen Counsel, and Sec.
(Last)         (First)         (Middle)
C/O 70 SIR JOHN ROGERSON'S QUAY
3. Date of Earliest Transaction (MM/DD/YYYY)
6/1/2020
(Street)
DUBLIN, L2 2
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares  6/1/2020    A    3008 (1) A $0.00  31655  D   
Ordinary Shares  6/1/2020    D    771 (2) D $165.65  30884 (3) D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy)  $182.22  6/1/2020    A     18168       (4) 6/1/2030  Ordinary Shares  18168  $0.00  18168  D   

Explanation of Responses:
(1)  All 3,008 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,504 on June 1, 2022; 752 on June 1, 2023 and 752 on June 3, 2024.
(2)  771 shares were withheld from the 2,500 restricted shares that vested on June 1, 2020. These 771 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,500 ordinary shares were awarded to Mr. Zangerle on June 1, 2016. These vested shares were valued at the NYSE closing market price on June 1, 2020.
(3)  15,980 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 3,636 on May 31, 2022; 2,502 on May 31, 2022; 1,504 on June 1, 2022; 834 on May 31, 2023; 752 on June 1, 2023 and 752 on June 3, 2024.
(4)  This option becomes exercisable as follows: 4,542 on June 1, 2021; 4,542 on June 1, 2022; 4,542 on June 1, 2023 and 4,542 on June 3, 2024.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Zangerle John Adam
C/O 70 SIR JOHN ROGERSON'S QUAY
DUBLIN, L2 2


Sr. VP, Gen Counsel, and Sec.

Signatures
/s/ Ronald E. Snyder, Authorized Representative under Power of Attorney 6/3/2020
**Signature of Reporting Person Date
STERIS (NYSE:STE)
Historical Stock Chart
From Sep 2020 to Oct 2020 Click Here for more STERIS Charts.
STERIS (NYSE:STE)
Historical Stock Chart
From Oct 2019 to Oct 2020 Click Here for more STERIS Charts.